In an accompanying Perspective, Richard Steketee (PATH, Seattle, USA) agrees: while the trials confirmed that MQ is safe
during pregnancy and showed that the drug can reduce rates of
malaria infection and maternal illness, the lack of obvious benefit for fetal health and the poor tolerability are barriers to recommending MQ..